[go: up one dir, main page]

WO2011014611A3 - Préparation de l'olmésartan médoxomil - Google Patents

Préparation de l'olmésartan médoxomil Download PDF

Info

Publication number
WO2011014611A3
WO2011014611A3 PCT/US2010/043640 US2010043640W WO2011014611A3 WO 2011014611 A3 WO2011014611 A3 WO 2011014611A3 US 2010043640 W US2010043640 W US 2010043640W WO 2011014611 A3 WO2011014611 A3 WO 2011014611A3
Authority
WO
WIPO (PCT)
Prior art keywords
olmesartan medoxomil
preparation
processes
medoxomil
preparing olmesartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2010/043640
Other languages
English (en)
Other versions
WO2011014611A2 (fr
Inventor
Naveen Kumar Kolla
Nagaraju Manne
Anitha Naredla
Sachin Gulabrao Shinde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2011014611A2 publication Critical patent/WO2011014611A2/fr
Publication of WO2011014611A3 publication Critical patent/WO2011014611A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des procédés de préparation de l'olmésartan médoxomil. Dans les modes de réalisation, les procédés de préparation de l'olmésartan médoxomil ne nécessitent pas d'isoler un ou plusieurs composés intermédiaires.
PCT/US2010/043640 2009-07-30 2010-07-29 Préparation de l'olmésartan médoxomil Ceased WO2011014611A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1810/CHE/2009 2009-07-30
IN1810CH2009 2009-07-30
US29336110P 2010-01-08 2010-01-08
US61/293,361 2010-01-08

Publications (2)

Publication Number Publication Date
WO2011014611A2 WO2011014611A2 (fr) 2011-02-03
WO2011014611A3 true WO2011014611A3 (fr) 2011-07-21

Family

ID=43529930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/043640 Ceased WO2011014611A2 (fr) 2009-07-30 2010-07-29 Préparation de l'olmésartan médoxomil

Country Status (1)

Country Link
WO (1) WO2011014611A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101630885B1 (ko) 2008-06-09 2016-06-15 다이이찌 산쿄 가부시키가이샤 1-비페닐메틸이미다졸 화합물의 제조 방법
ES2527686T3 (es) 2009-04-28 2015-01-28 Daiichi Sankyo Company, Limited Procedimiento de producción de olmesartán medoxomil
CA2760031C (fr) 2009-04-28 2015-03-10 Daiichi Sankyo Company, Limited Cristaux solvates d'acetone de trityl olmesartan medoxomil
EP2739619B1 (fr) * 2011-08-05 2015-09-16 Lupin Limited Procédé de préparation d'olmésartan médoxomil
CN104220717B (zh) 2012-02-21 2017-05-10 阿凯提兹动力公司 二冲程循环内燃发动机及其运转方法
CN105418593A (zh) * 2015-11-25 2016-03-23 蚌埠丰原涂山制药有限公司 一种奥美沙坦酯关键中间体及奥美沙坦酯的制备方法
CN105481842A (zh) * 2015-12-15 2016-04-13 江苏中邦制药有限公司 一种奥美沙坦酯的制备方法
CN105906614A (zh) * 2016-05-12 2016-08-31 山东罗欣药业集团股份有限公司 一种奥美沙坦酯的制备方法
CN110452228A (zh) * 2019-09-05 2019-11-15 黄冈鲁班药业股份有限公司 高纯度三苯基奥美沙坦乙酯的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069141A1 (en) * 2004-09-02 2006-03-30 Lilach Hedvati Preparation of olmesartan medoxomil
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
US20090131680A1 (en) * 2005-07-29 2009-05-21 Krka Process for the preparation of olmesartan medoxomil

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069141A1 (en) * 2004-09-02 2006-03-30 Lilach Hedvati Preparation of olmesartan medoxomil
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
US20090131680A1 (en) * 2005-07-29 2009-05-21 Krka Process for the preparation of olmesartan medoxomil

Also Published As

Publication number Publication date
WO2011014611A2 (fr) 2011-02-03

Similar Documents

Publication Publication Date Title
WO2011014611A3 (fr) Préparation de l'olmésartan médoxomil
IL238437A0 (en) Method for preparing 3-aryl-5-trifluoromethyl-5,4-dihydro-isoxazoles
SI2334668T1 (sl) Postopek priprave intermediata olmesartan medoksomila
WO2011003902A3 (fr) Matériau d'embolisation polymère visible multimodal
WO2010117738A3 (fr) Formes à l'état solide de sels de sitagliptine
WO2011133504A3 (fr) Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes
WO2010015657A3 (fr) Nouveaux alcoxypyrazoles
WO2012054664A3 (fr) Compositions d'encres
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
IL216728A0 (en) Novel method for preparing rosuvastatin. intermediated compounds useful for preparing same, and method for preparing same
ZA201204759B (en) Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
IL217057A0 (en) Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
WO2008075205A3 (fr) Procédé amélioré de préparation de la voriconazole
WO2010039885A3 (fr) Formes cristallines du dexlansoprazole
ZA201203155B (en) Method for isolating methylglycinenitrile-n,n-diacetonitrile
IL215966A0 (en) Method for producing olmesartan medoxomil
EP2585441A4 (fr) Procédé de préparation d'olmésartan médoxomil
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
WO2010091169A3 (fr) Préparation de valsartan
AP2011005999A0 (en) Process for the preparation of olmesartan medoxomil.
EP2634182B8 (fr) Procédé de préparation de 1,3,5-trioxane
EP2634183B8 (fr) Procédé de préparation de 1,3,5-trioxane
WO2010081163A3 (fr) Procédé de 2-sulfatation de glycosides
WO2010059916A3 (fr) Préparation de docétaxel
ZA201201715B (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo{[2,2.1]hept-5-enes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10805022

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 430/CHENP/2012

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10805022

Country of ref document: EP

Kind code of ref document: A2